VISTAGEN THERAPEUTICS INC
VTGN·92840H400·US·Common Stock·Healthcare - Biotechnology-13D/G
VTGN (VISTAGEN THERAPEUTICS INC) is held by 33 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($900,442), TWO SIGMA INVESTMENTS, LP ($268,387), GEODE CAPITAL MANAGEMENT, LLC ($259,170). Net institutional sentiment: Mixed.
33
Holders
Avg rating(6 Elite)
$2.9M
Total Value
51% (42)
Fund Consensus
18 buying - 17 selling
Who's Trading
ActivistCYChen Yu10.0%May 15, 2026
ActivistSTStemPoint Capital LP1.5%Feb 17, 2026
ActivistCOCommodore Capital LP9.9%Feb 17, 2026
ActivistOAORBIMED ADVISORS LLC3.6%Feb 17, 2026
ActivistGPGreat Point Partners, LLC5.0%Feb 17, 2026
ActivistNANantahala Capital Management, LLC4.7%Feb 13, 2026
13F: Insider & Congress:
Showing 1-20 of 42
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer